SightGlass Vision Receives Breakthrough Device Designation from U.S. Food and Drug Administration

PRWeb
This post was originally published on this site

Decision is the Latest Milestone for Diffusion Optics Technology™ (DOT™) Spectacle Lenses Designed to Slow Myopia Progression in Children LOS ALTOS, Calif., Feb. 14, 2024 /PRNewswire/ — SightGlass Vision, a joint venture of CooperCompanies and EssilorLuxottica that develops innovative…